Browse result page of CancerPDF Database

Please click on CancerPDF_ID for detailed information about peptide.

CancerPDF_IDPeptide seqProtein NameFluidMass/ZProfiling TechniqueCancer Type Expression RegulationPUBMED ID
CancerPDF_ID9450 RPPGFSPFDes-Arg9 BradykininPlasma904.46MALDI-TOFColorectal cancer Higher median intensity for liver metastasis group and lower median intensity for adenoma and CRC groups than the controls. 26379225
CancerPDF_ID9451 NANAPlasma991.67MALDI-TOFColorectal cancer NA 26379225
CancerPDF_ID9452 NANAPlasma1015.66MALDI-TOFColorectal cancer NA 26379225
CancerPDF_ID9453 SHALQLNNRComplement C4-A/Complement C4-BPlasma1052.56MALDI-TOFColorectal cancer "Intensity was similar to controls, controversially, in adenoma and CRC groups was highest. " 26379225
CancerPDF_ID9454 RPPGFSPFRBradykininPlasma1060.57MALDI-TOFColorectal cancer Higher median intensity for liver metastasis group and lower median intensity for adenoma and CRC groups than the controls. 26379225
CancerPDF_ID9455 RPPGFSPFRoxidated BradykininPlasma1076.56MALDI-TOFColorectal cancer Higher median intensity for liver metastasis group and lower median intensity for adenoma and CRC groups than the controls. 26379225
CancerPDF_ID9456 HWESASLLRComplement C3Plasma1098.57MALDI-TOFColorectal cancer "Lower intensity in control, adenoma, early,late CRC and much more lower in liver metastasis group." 26379225
CancerPDF_ID9457 THRIHWESAComplement C3Plasma1136.57MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9458 LQLNNRQIRComplement C4-A/Complement C4-BPlasma1154.68MALDI-TOFColorectal cancer "Intensity was similar to controls, controversially, in adenoma and CRC groups was highest. " 26379225
CancerPDF_ID9459 IHWESASLLRComplement C3Plasma1211.65MALDI-TOFColorectal cancer Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. 26379225
CancerPDF_ID9460 ALQLNNRQIRComplement C4-A/Complement C4-BPlasma1225.72MALDI-TOFColorectal cancer "Intensity was similar to controls, controversially, in adenoma and CRC groups was highest. " 26379225
CancerPDF_ID9461 ITHRIHWESAComplement C3Plasma1249.65MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9462 MEPLGRQLTSGPAlpha-2-antiplasminPlasma1285.66MALDI-TOFColorectal cancer Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. 26379225
CancerPDF_ID9463 RHDWGHEKQRKininogen-1Plasma1348.63MALDI-TOFColorectal cancer Not significant in annova test 26379225
CancerPDF_ID9464 RIHWESASLLRComplement C3Plasma1367.77MALDI-TOFColorectal cancer Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. 26379225
CancerPDF_ID9465 KITHRIHWESAComplement C3Plasma1377.72MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9466 GLEEELQFSLGSKComplement C4-A/Complement C4-BPlasma1436.72MALDI-TOFColorectal cancer Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. 26379225
CancerPDF_ID9467 SHALQLNNRQIRComplement C4-A/Complement C4-BPlasma1449.77MALDI-TOFColorectal cancer Lower intensity in liver metastasis group than adenoma and CRC groups 26379225
CancerPDF_ID9468 SKITHRIHWESAComplement C3Plasma1464.77MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9469 NGFKSHALQLNNRComplement C4-A/Complement C4-BPlasma1499.79MALDI-TOFColorectal cancer Lower intensity in liver metastasis group than adenoma and CRC groups 26379225
CancerPDF_ID9470 RPHFFFPKSRIVClusterinPlasma1530.86MALDI-TOFColorectal cancer Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. 26379225
CancerPDF_ID9471 SSKITHRIHWESAComplement C3Plasma1551.82MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9472 THRIHWESASLLRComplement C3Plasma1605.87MALDI-TOFColorectal cancer Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. 26379225
CancerPDF_ID9473 GPPDVPDHAAYHPFRInter-alpha-trypsin inhibitor heavy chain H4Plasma1675.8MALDI-TOFColorectal cancer Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. 26379225
CancerPDF_ID9474 ITHRIHWESASLLRComplement C3Plasma1718.95MALDI-TOFColorectal cancer Similar intensity into the case groups. 26379225
CancerPDF_ID9475 SKITHRIHWESASLLComplement C3Plasma1777.98MALDI-TOFColorectal cancer Higher than adenoma and CRC groups 26379225
CancerPDF_ID9476 GFKSHALQLNNRQIRComplement C4-A/Complement C4-BPlasma1782MALDI-TOFColorectal cancer Higher intensity in liver metastasis than adenoma and CRC groups. 26379225
CancerPDF_ID9477 KITHRIHWESASLLRComplement C3Plasma1847.04MALDI-TOFColorectal cancer "Low expression in control, adenoma, early,late CRC and much more lower in liver metastasis group." 26379225
CancerPDF_ID9478 SSKITHRIHWESASLLComplement C3Plasma1865MALDI-TOFColorectal cancer Similar intensity into the case groups. 26379225
CancerPDF_ID9479 GLEEELQFSLGSKINVKComplement C4-A/Complement C4-BPlasma1891.02MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225
CancerPDF_ID9480 NGFKSHALQLNNRQIRComplement C4-A/Complement C4-BPlasma1896.03MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225
CancerPDF_ID9481 NGFKSHALQLNNRQIR(NH4)Complement C4-A/Complement C4-BPlasma1913.01MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225
CancerPDF_ID9482 SKITHRIHWESASLLRComplement C3Plasma1934.07MALDI-TOFColorectal cancer "Low expression in control, adenoma, early,late CRC and much more lower in liver metastasis group." 26379225
CancerPDF_ID9483 SSKITHRIHWESASLLRComplement C3Plasma2021.1MALDI-TOFColorectal cancer "Low expression in control, adenoma, early,late CRC and much more lower in liver metastasis group." 26379225
CancerPDF_ID9484 SSKITHRIHWESASLLRComplement C3Plasma2037.09MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9485 SSKITHRIHWE(Na)SASLLRComplement C3Plasma2043.1MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9486 SSKITHRIHWE(K)SASLLRComplement C3Plasma2059MALDI-TOFColorectal cancer "Expression levels similar for liver metastasis and controls, but for adenoma and CRC groups was higher than controls." 26379225
CancerPDF_ID9487 QLGLPGPPDVPDHAAYHPFRInter-alpha-trypsin inhibitor heavy chain H4Plasma2167.08MALDI-TOFColorectal cancer Higher intensity in CRC groups vs controls. 26379225
CancerPDF_ID9488 QGVNDNEEGFFSARGHRPLDFibrinogen beta chainPlasma2228.03MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225
CancerPDF_ID9489 KREEAPSLRPAPPPISGGGYRFibrinogen beta chainPlasma2235.21MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225
CancerPDF_ID9490 QGVNDNEEGFFSARGHRPLDKFibrinogen beta chainPlasma2356.13MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225
CancerPDF_ID9491 KHNLGHGHKHERDQGHGHQRKininogen-1Plasma2365.22MALDI-TOFColorectal cancer "Low expression in control and liver metastatis group as comapred to adenoma, early,late CRC group." 26379225
CancerPDF_ID9492 GLEEELQFSLGSKINVKVGGNSKComplement C4-A/Complement C4-BPlasma2433.3MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225
CancerPDF_ID9493 SSSYSKQFTSSTSYNRGDSTFESKFibrinogen alpha chainPlasma2681.21MALDI-TOFColorectal cancer "Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups." 26379225